ADJUVANT THERAPY FOR PANCREATIC CANCER: Current Treatment Approaches and Future Challenges

This publication has 61 references indexed in Scilit:

• A Phase I Clinical Trial of Lethally Irradiated Allogeneic Pancreatic Tumor Cells Transfected with the GM-CSF Gene for the Treatment of Pancreatic Adenocarcinoma. The Johns Hopkins Oncology Center, Baltimore, Maryland
  Human Gene Therapy, 1998
• Chemo-Radiotherapy For Localized Pancreatic Cancer: Increased Dose Intensity and Reduced Acute Toxicity with Concomitant Radiotherapy and Protracted Venous Infusion 5-Fluorouracil
  International Journal of Radiation Oncology*Biology*Physics, 1998
• Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Long-Term Survival After Curative Resection for Pancreatic Ductal Adenocarcinoma
  Annals of Surgery, 1996
• Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation
  The Lancet, 1995
• Resection Margins in Carcinoma of the Head of the Pancreas
  Annals of Surgery, 1993
• High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (radiation therapy oncology group protocol 8801)
  Cancer, 1992
• Patterns of failure after curative resection of pancreatic carcinoma
  Cancer, 1990
• Survival After Pancreatoduodenectomy
  Annals of Surgery, 1990
• Intraoperative Electron Beam Irradiation for Patients with Unresectable Pancreatic Carcinoma
  Annals of Surgery, 1984